20
Cipla Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Salmeterol xinafoate, Micronised, grades I and II, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2006-296 - Rev 05
This Chemical Type CEP, issued on April 12, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1765 associated with this CEP further emphasizes